The present invention relates to pyridazinone derivatives of general formula I, wherein the groups A, G and R
1
are as defined in the application, the tautomers thereof, stereoisomers thereof, the mixtures thereof and the salts thereof, which have valuable pharmacological properties, and in particular bind to the GPR119 receptor and modulate its activity.